Orchid Pharma Limited

NSE:ORCHPHARMA.NS

784.9 (INR) • At close May 8, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20242023202220212020201920182017201620152014201220112010200920082007200620052004
Operating Activities:
Net Income 921.665463.183-19.512-1,165.3-1,310.701694.079-3,989.628-5,437.759-2,961.848-1,311.019-3,720.182754.3631,715.6514,698.347-338.1652,285.65925.566650.103220.871250.359
Depreciation & Amortization 332.371547.868870.2461,089.1641,179.2781,299.4341,333.1291,410.5171,452.6652,163.9081,679.4861,537.3651,335.0421,548.9961,339.9251,006.784850.893858.176637.813574.502
Deferred Income Tax 0000000000-46.771000000000
Stock Based Compensation 00000000004.725000000000
Change In Working Capital -78.378-790.621595.657-369.595618.851-1,104.429-383.1234,491.654181.879-2,369.93542.0463,568.23272.3561,190.722-1,172.562-1,184.223-1,843.838-2,395.201-754.075-935.619
Accounts Receivables 196.467-416.535-229.194-820.248440.11-91.498451.381,053.726-514.25-4,065.344-1,041.19500000000-913.29
Inventory -354.881-560.81725.369-334.985140.628239.661175.131305.977100.7891,695.411,083.241-511.003-1,949.863,456.146-1,190.993-375.409-1,634.639-475.859-1,130.774-260.436
Accounts Payables 548.513139.141473.627179.30576.919-576.765-824.601425.116595.340000-634.10700000238.107
Other Working Capital -468.47747.59325.855606.333-38.806-675.827-185.0332,706.8350004,079.2352,022.216-1,631.31718.431-808.814-209.199-1,919.342376.6990
Other Non Cash Items 84.262-37.05-521.645681.591320.602-768.843,131.4273,545.1313,449.264-943.4263,161.8191,510.239198.246-7,781.235629.817-5.3161,003.492788.971766.311-25.784
Operating Cash Flow 1,259.92183.38924.746235.86808.03120.24491.8054,009.5432,121.96-2,460.4711,121.1237,370.1993,321.295-343.17459.0152,102.895936.113-97.951870.92-136.542
Investing Activities:
Investments In Property Plant And Equipment -648.148-849.131-144.035-6.04-42.424-66.266-62.104-86.757-14.663-836.767-7,439.866-2,940.446-3,867.14-2,246.897-4,813.203-5,456.049-4,779.545-1,841.163-2,689.26-1,710.709
Acquisitions Net 001,139.08100000.0770000016,374.2550000.15035.4
Purchases Of Investments 0-53.073-128.4460000-1.50000000-7.28200-1.2050
Sales Maturities Of Investments 00128.446000000000000000.150.27538.877
Other Investing Activites -2,472.138590.065134.316678.0911,713.545520.997-218.456-1,671.3080.1039,727.811866.2529.958193.0320.24143.5089.37.44412.28934.728-0.513
Investing Cash Flow -3,120.286-312.1391,129.362672.0511,671.121454.731-280.56-1,759.488-14.568,891.044-6,573.614-2,930.488-3,674.10814,127.599-4,769.695-5,454.031-4,772.101-1,828.574-2,655.462-1,636.945
Financing Activities:
Debt Repayment -2,085.472633.921-1,847.864-1,250.8-2,900.0920377.109-1,028.036-398.286010,176.882-2,099.5941,717.039-6,869.4586,028.273,915.809-1,318.927-768.9492,390.0711,873.149
Common Stock Issued 3,919.421000400000184.345737.381.6620001,095.1546.78810.024799.69373.8040
Common Stock Repurchased 00000000000000000000
Dividends Paid 00000000000-249.016-818.009-82.414-230.631-231.046-225.126-155.676-146.123-133.444
Other Financing Activities -163.545-322.257-320.117-399.087-3.253-2.996-43.206-3,623.917-2,465.363-4,720.343-5,749.344-2,452.845-1,676.565-3,816.18-2,581.952-1,217.9186,386.1722,024.983-848.6140
Financing Cash Flow 1,670.404311.664-2,167.981-1,649.887-2,503.345-2.996333.903-4,651.953-2,863.649-3,982.9634,429.2-4,801.455-777.535-10,768.0524,310.8412,473.6334,852.1431,900.0481,769.1381,739.705
Other Information:
Effect Of Forex Changes On Cash 000000000000000.00200000
Net Change In Cash -189.962182.905-113.873-741.976-24.194571.979145.148-2,943.419-756.2492,447.611-1,023.291-361.744-1,130.3483,016.3770.163-877.5031,040.243-26.477-15.4040
Cash At End Of Period 36.009225.97143.066156.939898.915923.109351.13205.9823,149.4012,447.611-1,023.2911,769.172,130.9143,261.262244.884244.7211,122.22481.981108.458121.129